Johnson & Johnson: Johnson & Johnson Reports First Quarter 2025 Sales Growth, Forecasts $400 Million in Tariff-Related Costs, and Issues Updated Guidance

NEW BRUNSWICK, N.J.-Johnson & Johnson (NYSE: JNJ) announced financial results yesterday for the first-quarter of 2025 and lifted its sales forecast for full-year 2025. J&J reported 2025 first-quarter sales growth of 2.4 percent to $21.9 billion with operational growth of 4.2 percent. In the company's MedTech segment, vision grew 1.7 percent in the first quarter with operational growth of 3.7 percent year-over-year, the announcement said. The company also stated on a conference call that it expects about $400 million in tariff-related costs this year, mostly related to China.